Kimberly R Jordan

24PUBLICATIONS
154CO-AUTHORS
Molecular targetsPeripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 16, 2026
Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial.

|Oct 01, 2026
Stromal innervation is prognostic in non-muscle-invasive bladder cancer and predicted by a distinct microenvironmental transcriptomic signature.

|Aug 19, 2026
Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma.

|May 18, 2026
Cross-assay RNA modeling reveals cancer biomarkers.

|Dec 04, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

Pageof 4

Frequent Collaborators

10 joint publications

Benjamin G Bitler

6 joint publications

Elizabeth R Woodruff

5 joint publications

Tomomi M Yamamoto

4 joint publications

Lily L Nguyen